Infections associated with uremia and dialysis

Infectious Disease Clinics of North America

Volumn 15, Issue 2, 2001, Pages 385-406

  Minnaganti, Venkat R ^b   Cunha, Burke A ^b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTEREMIA; BONE INFECTION; CARDIOVASCULAR INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; CHRONIC KIDNEY FAILURE; CLOSTRIDIUM DIFFICILE; DIALYSIS; DIVERTICULITIS; ENTEROCOCCUS; FEVER; GASTROINTESTINAL INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; INFECTION; INFECTION PREVENTION; INFECTION RISK; LUNG INFECTION; REVIEW; SEPTIC SHOCK; SKIN INFECTION; UREMIA; URINARY TRACT INFECTION; VIRUS HEPATITIS;

EID: 0034964172     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70152-5     Document Type: Article

References (128)

1. Clinical considerations in hemodialysis access infection
2. Tuberculosis in patients with end-stage renal disease
3. Depressed natural killer cell activity in uremia: Evidence for immunosuppressive factor in uremic sera
4. Nosocomial infections associated with peritoneal dialysis
5. Clostridium difficile infection - A poor prognostic sign in uremic patients?
6. Meningitis caused by Escherichia coli 09 in a patient with uremia
7. Xanthomonas maltophila peritonitis in a patient undergoing peritoneal dialysis
8. Epidemiological perspective on infections in chronic dialysis patients
9. Deferoxamine therapy and mucormycosis in dialysis patients: Report of an international registry
10. Risk factors associated with permanent access-site infections in chronic hemodialysis patients
11. Outcomes of single organism peritonitis in peritoneal dialysis: Gram-negatives versus gram-positives in the Network 9 Peritonitis Study
12. Listeria monocytogenes meningitis in an HIV positive hemodialysis patient
13. Pseudomonas paucimobilus in a hemodialysis patient: Report of a case and review of the literature
14. Hepatitis G virus infection in hemodialysis and in peritoneal dialysis patients
15. Diffusion of HCV through peritoneal membrane in HCV positive patients treated with continuous ambulatory peritoneal dialysis
16. Recommendations for preventing the spread of vancomycin resistant enterococci
17. Occurrence of pyuria and bacteruria in asymptomatic hemodialysis patients
18. Impaired phagocytosis in renal failure is mediated by secondary hyperparathyroidism
19. Risk of tuberculosis in dialysis patients: A population-based study
20. Staphylococcus aureus nasal carriage in hemodialysis patients: Its role in infection and approaches to prophylaxis
21. Comparative morbidity among hemodialysis and continuous ambulatory peritoneal dialysis patients
22. Canadian hemodialysis morbidity study
23. Chemotaxis in acute renal failure
24. Staphylococcus aureus infections during peritoneal dialysis
25. Infective endocarditis and access site infections in patients on hemodialysis
26. Cytomegalovirus and Legionella as a cause of liver enzyme elevations in hemodialysis patients
27. Enterobacter cloacae graft infection/bacteremia in a hemodialysis patient
28. Clostridium difficile colitis associated with chronic renal failure
29. Prevalence of Helicobacter pylori in patients with end-stage renal failure and renal transplant recipients
30. Hepatitis C virus in renal disease
31. The immune system in end-stage renal disease
32. T cells and B cells in chronic renal failure
33. Treatment of hepatitis C infection in patients with renal disease
34. Immune system to uremia
35. Septicemia in patients on chronic hemodialysis
36. Fungal peritonitis in patients receiving peritoneal dialysis: Experience with 11 patients and review of the literature
37. Does pyuria indicate infection in asymptomatic dialysis patients?
38. Peritoneal dialysis-associated peritonitis caused by Alcaligenes xylosoxidans
39. Pasteurella multocida peritonitis in an HIV-positive patient on continuous cycling peritoneal dialysis
40. Hepatitis B virus infection in dialysis patients
41. GBV-C/HGV infection in end-stage renal disease
42. Hepatitis G virus infection in chronic dialysis patients and kidney transplant recipients
43. Nosocomial infections associated with hemodialysis
44. Vancomycin resistant enterococci in hemodialysis patients
45. Prevalence of Helicobacter pylori in patients with chronic renal failure
46. Serratia peritonitis in hemodialysis patients
47. Excessive levels of gram-negative bacteria in hemodialysis machines because of inadequate cleaning guidelines
48. Dysfunction of polymorphonuclear leucocytes in uremia
49. Effect of malnutrition and uremia on impaired cellular host defense
50. Uremia and infection: Mechanisms of impaired cellular host defense
51. Metabolic response of neutrophils to uremia and dialysis
52. Environmental mycobacterial peritonitis complicating peritoneal dialysis: Three cases and review
53. Cytomegalovirus infection in dialysis patients
54. Reduction of Staphylococcus aureus nasal carriage and infection in dialysis patients
55. Approach to immunization in the immunosuppressed host
56. Biocompatibility and risk of infection in haemodialysis patients
57. Four-valve poly-microbial endocarditis caused by Pseudomonas aeruginosa and Serratia marcescens
58. Hepatitis in patients with end-stage renal disease
59. Interferon-alpha in chronic hepatitis C infection in dialysis patients
60. Neisseria cinerea bacteremia in a hemodialysis patient
61. The use of vaccines in renal failure
62. Outcome and complications of temporary hemodialysis catheters
63. Intestinal mucormycosis in a hemodialysis patient treated with deferoxamine
64. Incidence of cytomegalovirus infection in uremic patients
65. Infection in patients on maintenance hemodialysis
66. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis
67. Comparison of autogenous fistula versus expanded polyethylene graft for access in hemodialysis
68. Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanisms, and associated risks
69. Incidence of subclavian dialysis catheter related infections
70. Fungal urinary tract infections in patients at risk
71. Cardiovascular surgery in end-stage renal failure
72. Exit site care and exit site infections in continuous ambulatory peritoneal dialysis: Results of a randomized multicenter trial
73. Bacterial endocarditis in regularly dialyzed patients
74. Osteomyelitis in hemodialysis patients
75. Clostridium difficile-associated colitis in uremic patients
76. Recurrent peritonitis: Evidence for possible viral etiology
77. Neutrophil and monocyte alterations in chronic dialysis patients
78. Neutrophil and monocyte alterations in chronic dialysis patients
79. Fever: Thermal regulation and alterations in end-stage renal disease patients
80. An outbreak of Salmonella enteritis and septicemia in a population of uremic patients: A review of four cases, including infection of an arteriovenous fistula
81. Meningitis caused by Streptococcus in adults
82. Unusual causes of peritonitis in patients undergoing peritoneal dialysis with emphasis on Listeria monocytogenes
83. Endogenous endophthalmitis caused by Serratia marcescens
84. Infective endocarditis in patients receiving long-term hemodialysis
85. Nosocomial acquisition of Clostridium difficile infection
86. Renal failure and infection
87. Leukophagocytosis and bactericidal activity in chronic renal failure and infection
88. Helicobacter pylori and uremic gastritis: A histopathologic study and a correlation with endoscopic and bacteriologic findings
89. Nasal mupirocin prevents Staphylococcus aureus exit site infection during peritoneal dialysis
90. A 1990s perspective of hepatitis C, human immunodeficiency virus, and tuberculosis infections in dialysis patients
91. Pasteurella multocida peritonitis in peritoneal dialysis
92. Cytomegalovirus infection in patients receiving long-term hemodialysis
93. Vancomycin-resistant enterococcus infection is a rare complication in patients receiving PD on an outpatient basis
94. Current status of CAPD and CCPD
95. Access problems plague both peritoneal dialysis and hemodialysis
96. Bacteremic infection in hemodialysis
97. Spinal epidural abscess in hemodialysis patients: Report of three cases and review of the literature
98. Hepatitis C virus infection in dialysis: A continuing problem
99. Hepatitis C virus infection in dialysis and renal transplantation
100. High incidence of subclavian dialysis catheter-related bacteremias
101. Staphylococcus aureus colonization and infection in patients on chronic ambulatory peritoneal dialysis
102. Peritonitis as a complication of peritoneal dialysis
103. Septicemia in dialysis patients: Incidence, risk factors, and prognosis
104. Tuberculous peritonitis
105. Bacterial endocarditis with pulmonary edema necessitating mitral valve replacement in a hemodialysis dependent patient
106. Bacterial endocarditis in hemodialysis patients
107. Colonization with vancomycin resistant enterococci in chronic hemodialysis patients
108. CAPD peritonitis: Incidence, pathogens, diagnosis, and management
109. Dialysis associated mucormycosis and deferoxamine treatment: A case report with review of the role of oxygen radicals
110. Cytomegalovirus infection and chronic hemodialysis
111. Tuberculin and anergy skin testing of patients receiving long term hemodialysis
112. Cryptococcal peritonitis in patients on peritoneal dialysis
113. Preventing Staphylococcus aureus infection during chronic peritoneal dialysis
114. Pathobiology of the role of in infection
115. Xanthomonas maltophilia peritonitis in uremic patients receiving continuous ambulatory peritoneal dialysis
116. National surveillance of dialysis associated diseases in the United States 1995
117. National surveillance of dialysis associated diseases in the United States 1990
118. Current approach to exit-site infections in patients on peritoneal dialysis
119. USRDS 1997 Annual Data Report
120. Reduced phagocytosis in hemodialyzed patients: In vivo and in vitro mechanisms
121. Influence of uremia and haemodialysis on host defense and infection
122. Microbiological aspects of peritonitis associated with continuous ambulatory peritoneal dialysis
123. New criteria for management of catheter infections in peritoneal dialysis patients using ultrasonography
124. Gastroduodenal mucosa in uremia: Endoscopic and histologic correlation and prevalence of helicobacter-like organisms
125. Serological evidence for reactivation of EBV infection due to uremic immunodeficiency
126. Tuberculosis infection and anergy in hemodialysis patients
127. Clinical implications of coinfection with a novel DNA virus (TTV) in hepatitis C virus carriers on maintenance hemodialysis
128. Complications from permanent hemodialysis vascular access